Yifan Pharmaceutical Co., Ltd. (002019.SZ) SHZ
10.33
-0.17(-1.62%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
10.33
-0.17(-1.62%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
4098
First IPO Date
July 13, 2004
| Name | Title | Pay | Year Born |
| Kai Wang | Head of Accounting | 0 | N/A |
| Feng Wang | Executive President | 0 | 1973 |
| Xian Feng Cheng | Chairman of the Board of Directors, President & GM | 0 | 1968 |
| Xing Lin | Deputy GM, Vice President & Director | 0 | 1986 |
| Deqi Feng | Board Secretary, Deputy GM, Vice President & Director | 0 | 1979 |
| William Tan | Director of Sales Team | 0 | N/A |
| Ximing Li | Deputy GM & Vice President | 0 | 1961 |
| Yuhong Geng | Deputy GM & Vice President | 0 | 1971 |
| Dawei Zhang | VP & CFO | 0 | 1981 |
Yifan Pharmaceutical Co., Ltd. produces and sells drugs and medicines in China and internationally. It provides drugs across gynecology, pediatrics, orthopedics, and dermatology therapeutic areas; therapeutic infusion solutions; and pantothenic acid and Provitamin B5 products. The company also provides Chinese traditional medicines, women's health products, and blood tumor drugs. In addition, it offers APIs, including feed additives/animal health products, skin and hair care ingredients, functional food additives, and fine chemicals; and PBAT/PBS biodegradable resins and PVB films. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is based in Hangzhou, China.